Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Histidine and Lodosyn for Fatigue in Multiple Sclerosis
NCT04764383Phase 2Withdrawn
- Sponsor
- University of Miami
- Start
- Jan 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of l-histidine in multiple sclerosis (MS), sponsored by University of Miami. Planned start Jan 2022; status: withdrawn.
02
Drugs
l-histidine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04764383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04764383.